We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Akciğer Kanserine Eşlik Eden Plevral Effüzyonların Benign-Malign Ayırımında, Biyokimyasal Değişkenler ve Plevral Sıvının Hücre Sayımı Kullanılabilir mi?
- Authors
DENİZ, Sami; GÜLCE, Zübeyde; ÇELDİR, Jülide Emre; AYDEMİR, Yusuf; ALİZOROĞLU, Dursun; ERBAYCU, Ahmet Emin
- Abstract
Aim: Pleural effusion is frequently encountered in patients with lung cancer. Malignant-benign differentiation of the fluid is very important for treatment decision because malignant fluid is considered as the inoperability criterion. However, this distinction is not clinically feasible and may require a cytological examination of the fluid via invasive procedures. The aim of this study was to determine whether there was any difference between laboratory results of malignant and benign pleural fluid in our study. METHODS We retrospectively evaluated 135 patients with cytologically diagnosed lung cancer and underwent benign-malignant differentiation of pleural effusion. Benign and malignant groups were compared in terms of fluid biochemistry, blood gas and cell count. RESULTS: 104 patients were male, 31 were female and the mean age was 63.5 ±11.4. Histologically adenocarcinoma was determined as the most common (56%). Right pleural effusion was present in 58.5% of the patients. Malignant effusion rate was higher in women. (Malign / Benign, W: 21/10, M: 48/56). Albumin, protein, erythrocyte count (RBC) and hematocrit (Htc) values in pleural fluid were higher in the malignant group (P: 0.001, 0.018, 0.009, 0.016, respectively). Cutting point for albumin, 2.85 and OR: 2.02, for Htc, 4.7 and OR: 6.25, for RBC, 300 and OR: 6.25, for protein, 4.45 and OR: 2.08. CONCLUSION: In our study, the values of albumin, Htc, RBC and protein in pleural fluid were higher in malignant pleural effusion.
- Publication
Bezmialem Science, 2018, Vol 6, Issue 4, p1
- ISSN
2148-2373
- Publication type
Article
- DOI
10.14235/bs.2018.2130